ReviewEpidemics2022
The challenges of data in future pandemics.
Review in Epidemics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Impact of Chronic Kidney Disease Severity on COVID-19 Outcomes: A Retrospective Cohort Study.Healthcare (Basel, Switzerland) · 2026Article
- Leveraging synthetic and genetic data to improve epidemic forecasting.PLoS computational biology · 2026Article
- Global approaches to infectious disease surveillance and modeling.Nature medicine · 2026Review
- Rapid Epidemiological Data Collection on Social Media for COVID-19: Comparative Study Between Online Surveys and Conventional Cohorts.Journal of medical Internet research · 2026Observational
- Retrospective analysis of age-specific non-pharmaceutical interventions on wild-type SARS-CoV-2 in Canada.BMC public health · 2026Article
- Mobility-driven synthetic contact matrices as a scalable solution for real-time pandemic response modeling.Nature communications · 2026Article
- Article
- How mathematical modelling can inform outbreak response vaccination.BMC infectious diseases · 2024Review
- Using artificial intelligence and predictive modelling to enable learning healthcare systems (LHS) for pandemic preparedness.Computational and structural biotechnology journal · 2024Review
- Improving COVID-19 contact tracing and testing of exposed individuals in Cameroon using digital health technology: a cluster randomised trial.EClinicalMedicine · 2024Article
- Article
- Effectiveness assessment of non-pharmaceutical interventions: lessons learned from the COVID-19 pandemic.The Lancet. Public health · 2023Review
- Synergistic fight against future pandemics: Lessons from previous pandemics.Le infezioni in medicina · 2023Review
- Sudden Sensorineural Hearing Loss in the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland) · 2022Review
- Tracking the national and regional COVID-19 epidemic status in the UK using weighted principal component analysis.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2022Article
- RAMPVIS: Answering the challenges of building visualisation capabilities for large-scale emergency responses.Epidemics · 2022Article
- Challenges for modelling interventions for future pandemics.Epidemics · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The use of data has been essential throughout the unfolding COVID-19 pandemic. We have needed it to populate our models, inform our understanding, and shape our responses to the disease. However, data has not always been easy to find and access, it has varied in quality and coverage, been difficult to reuse or repurpose. This paper reviews these and other challenges and recommends steps to develop a data ecosystem better able to deal with future pandemics by better supporting preparedness, prevention, detection and response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.